AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQX:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and nine-month periods ended September 30, 2025. September Q3 Highlights: Aspira reported relatively flat total product revenues of $2.3 million for the third quarters of 2025 and 2024.

Delivered Q3 2025 Net Revenue of $124.7 million Achieved Q3 2025 Adjusted EBITDA1 of $31.1 million, representing a 24.9% margin Focused margin optimization fueled sequential Adjusted Gross Margin 1  growth of 300-basis points to 46.4% Drove strategic market densification with seven new stores added year-to-date, expanding nationwide footprint to 46 locations2 NEW YORK , Nov. 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today reported its financial results for the quarter ended September 30, 2025 ("Q3 2025"). Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP"), and all currency is in U.S. dollars.

Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., abio-analytical-based women's health company focused on gynecologic disease diagnostics, today announced it has executed a new laboratory services agreement with University of Texas Medical Branch at Galveston ("UTMB Galveston"), a part of the University of Texas System. The initial term of the agreement is 12 months and is part of the Company's redefined marketing strategy that has prioritized marketing the Company's health care solutions to larger organizations that enable Aspira to efficiently reach thousands of potential patients and their care providers with each new platform adoption.

NEW YORK , Oct. 20, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Monday, November 10, 2025, at 5:00 PM ET following the release of its third quarter 2025 financial results.  The earnings conference call may be accessed by dialing 1-888-699-1199.

NEW YORK , Sept. 30, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, entered into and closed, effective September 12, 2025, a $9,345,000 secured financing transaction with CF Bank, pursuant to which AWH mortgaged real estate on three properties in Ohio (the "Ohio Mortgage Loan").

$2.95 Million PIPE $112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostics and disease management tools, today announced that it has received equity capital totaling $3.06 million from existing and new investors. The company has entered into a securities purchase agreement dated September 18, 2025, pursuant to which the Company has sold and issued an aggregate principal amount of $2.95 million in the form of a Unit Purchase, which includes Common Stock and a partial Warrant (the "Unit") in a private placement (the "Private Placement") with existing and new accredited investors, including members of the Board of Directors.

New Executive Brings 20+ Years of Accounting, Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced the appointment of Brian Hungerford as Chief Financial Officer, effective September 2, 2025. "We are pleased to announce the addition of Mr.

AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and six months ended June 30, 2025. The Company also reported early progress under its new leadership team.

Q2 2025 Net Revenue of $127.3 million and Adjusted EBITDA 1  of $28.6 million Tenth straight quarter of positive operating cash flow with $17.8 million generated Fully retired $60 million term loan via strategic refinancing Robust cash position of $95.3 million at quarter end NEW YORK , Aug. 7, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today reported its financial results for the quarter ended June 30, 2025 ("Q2 2025"). Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP"), and all currency is in U.S. dollars.

AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced the appointment of Jane Pine Wood to the Board of Directors, effective July 11, 2025. "We are pleased to welcome Jane Pine Wood to the Board of Directors," said Jack Fraser, Chairman of the Board of Directors of Aspira Women's Health.